» Articles » PMID: 38854175

The Use of Platelet-Rich Plasma and Stem Cell Injections in Musculoskeletal Injuries

Overview
Journal Cureus
Date 2024 Jun 10
PMID 38854175
Authors
Affiliations
Soon will be listed here.
Abstract

Injuries to the musculoskeletal (MSK) system can have a significant impact on an individual's activities of daily living, as this multifunctional unit is associated with physical movement. Treatment of MSK injuries often involves corticosteroid injections, supplements, pharmaceutical agents, and/or surgery. While these approaches have been shown to be effective for some patients over both the short and long term, they can be associated with limited relief, adverse effects, and/or decreases in activities of daily living. An unmet need exists to develop and/or implement more effective treatment approaches for MSK injuries. Treatment options being explored include platelet-rich plasma (PRP) and stem cell injections. This review outlines the current state of research evaluating PRP and stem cell injections in the treatment of various MSK injuries. A literature search was conducted using the PubMed database to identify the relevant published articles related to the use of PRP and/or stem cell injections for the treatment of MSK and cartilage injuries. PRP and stem cell injections have been shown to improve an individual's quality of life (QOL) and are associated with fewer side effects as compared to invasive standards of care in multiple MSK injuries such as plantar fasciitis, Achilles tendinopathy, acute muscle and tendon tears, ligament injuries, chondral and medial collateral ligament (MCL) knee injuries and arthritis, rotator cuff lesions, and avascular femoral necrosis. Specifically, these studies on PRP and stem cell injections suggest that both approaches are associated with a quicker return to activities of daily living while providing longer lasting relief without significant adverse events. The studies reviewed demonstrated PRP and stem cell approaches to be effective and safe for the treatment of certain MSK injuries, but as standardized protocols were not utilized across studies in the discussion of similar injuries, it was therefore difficult to compare their efficacy and safety. As such, further research is warranted to establish standardized research protocols across MSK injury studies to gain further insight into the efficacy, safety, and durability of PRP and stem cell injections.

Citing Articles

Use of platelet-rich plasma in rheumatic diseases.

Yessirkepov M, Fedorchenko Y, Zimba O, Mukanova U Rheumatol Int. 2024; 45(1):13.

PMID: 39739042 DOI: 10.1007/s00296-024-05776-1.

References
1.
Blanco-Rivera J, Elizondo-Rodriguez J, Simental-Mendia M, Vilchez-Cavazos F, Pena-Martinez V, Acosta-Olivo C . Treatment of lateral ankle sprain with platelet-rich plasma: A randomized clinical study. Foot Ankle Surg. 2019; 26(7):750-754. DOI: 10.1016/j.fas.2019.09.004. View

2.
Tuakli-Wosornu Y, Terry A, Boachie-Adjei K, Harrison J, Gribbin C, LaSalle E . Lumbar Intradiskal Platelet-Rich Plasma (PRP) Injections: A Prospective, Double-Blind, Randomized Controlled Study. PM R. 2015; 8(1):1-10. DOI: 10.1016/j.pmrj.2015.08.010. View

3.
Benyamin R, Trescot A, Datta S, Buenaventura R, Adlaka R, Sehgal N . Opioid complications and side effects. Pain Physician. 2008; 11(2 Suppl):S105-20. View

4.
Navani A, Li G, Chrystal J . Platelet Rich Plasma in Musculoskeletal Pathology: A Necessary Rescue or a Lost Cause?. Pain Physician. 2017; 20(3):E345-E356. View

5.
Peerbooms J, Lodder P, Den Oudsten B, Doorgeest K, Schuller H, Gosens T . Positive Effect of Platelet-Rich Plasma on Pain in Plantar Fasciitis: A Double-Blind Multicenter Randomized Controlled Trial. Am J Sports Med. 2019; 47(13):3238-3246. DOI: 10.1177/0363546519877181. View